These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 16890725)

  • 1. Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model.
    Yamanaka K; Hara I; Nagai H; Miyake H; Gohji K; Micallef MJ; Kurimoto M; Arakawa S; Kamidono S
    Cancer Immunol Immunother; 1999 Sep; 48(6):297-302. PubMed ID: 10473804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.
    Croce M; Meazza R; Orengo AM; Fabbi M; Borghi M; Ribatti D; Nico B; Carlini B; Pistoia V; Corrias MV; Ferrini S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1625-34. PubMed ID: 18324400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model.
    Sato R; Watanabe K; Matsushita Y; Watanabe H; Tamura K; Motoyama D; Otsuka A; Miyake H
    Anticancer Res; 2024 Apr; 44(4):1417-1423. PubMed ID: 38537988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The past, present, and future of immunotherapy for bladder tumors.
    Schneider T; Zhao L; Zhu Z; Gabrielyan G; Xiao H; Fajardo ED; Bai Q; Wakefield MR; Fang Y
    Med Oncol; 2022 Sep; 39(12):236. PubMed ID: 36175715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-21 receptor signaling is essential for control of hepatocellular carcinoma growth and immunological memory for tumor challenge.
    Zheng X; Zhou Y; Yi X; Chen C; Wen C; Ye G; Li X; Tang L; Zhang X; Yang F; Liu G; Li Y; Hou J
    Oncoimmunology; 2018; 7(12):e1500673. PubMed ID: 30524894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21: a pleiotropic cytokine with potential applications in oncology.
    Croce M; Rigo V; Ferrini S
    J Immunol Res; 2015; 2015():696578. PubMed ID: 25961061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological basis in the pathogenesis and treatment of bladder cancer.
    Thompson DB; Siref LE; Feloney MP; Hauke RJ; Agrawal DK
    Expert Rev Clin Immunol; 2015 Feb; 11(2):265-79. PubMed ID: 25391391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.
    Zhu Z; Shen Z; Xu C
    Mediators Inflamm; 2012; 2012():528690. PubMed ID: 22811589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.
    Stolfi C; Rizzo A; Franzè E; Rotondi A; Fantini MC; Sarra M; Caruso R; Monteleone I; Sileri P; Franceschilli L; Caprioli F; Ferrero S; MacDonald TT; Pallone F; Monteleone G
    J Exp Med; 2011 Oct; 208(11):2279-90. PubMed ID: 21987656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.
    Capitini CM; Fry TJ; Mackall CL
    Am J Immunol; 2009 Jan; 5(3):65-83. PubMed ID: 20182648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of ERK-1/2 in IL-21-induced cytokine production in leukemia cells and human monocytes.
    Fuqua CF; Akomeah R; Price JO; Adunyah SE
    Cytokine; 2008 Oct; 44(1):101-7. PubMed ID: 18707899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IL-21 in immune-regulation and tumor immunotherapy.
    di Carlo E; de Totero D; Piazza T; Fabbi M; Ferrini S
    Cancer Immunol Immunother; 2007 Sep; 56(9):1323-34. PubMed ID: 17447063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors.
    Søndergaard H; Frederiksen KS; Thygesen P; Galsgaard ED; Skak K; Kristjansen PE; Odum N; Kragh M
    Cancer Immunol Immunother; 2007 Sep; 56(9):1417-28. PubMed ID: 17285290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response.
    Furukawa J; Hara I; Nagai H; Yao A; Oniki S; Fujisawa M
    J Urol; 2006 Sep; 176(3):1198-203. PubMed ID: 16890725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of simultaneous transfer of interleukin-12 and interleukin-18 genes and its mechanism in a mouse bladder cancer model.
    Hikosaka S; Hara I; Miyake H; Hara S; Kamidono S
    Int J Urol; 2004 Aug; 11(8):647-52. PubMed ID: 15285756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-23 gene therapy for mouse bladder tumour cell lines.
    Kuramoto T; Fujii R; Nagai H; Belladonna ML; Yoshimoto T; Kohjimoto Y; Inagaki T; Hara I
    BJU Int; 2011 Sep; 108(6):914-21. PubMed ID: 21435151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-induced tumor immunogenicity.
    Cavallo F; Giovarelli M; Gulino A; Vacca A; Scala G; Forni G
    Immunol Ser; 1994; 61():183-93. PubMed ID: 8011743
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.